effect
(aspect of
placebo)
→
HasProperty
→
unknown
|
0.77 | |
placebo → HasProperty → effective | 0.67 | |
effect
(aspect of
placebo)
→
HasProperty
→
consistent
|
0.63 | |
placebo → HasA → effect | 0.58 | |
placebo → CapableOf → reduce pain | 0.56 | |
effect
(aspect of
placebo)
→
HasProperty
→
significant
|
0.55 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
observed
|
0.54 | |
effect
(aspect of
placebo)
→
HasProperty
→
temporary
|
0.54 | |
effect
(aspect of
placebo)
→
HasProperty
→
reversible
|
0.53 | |
placebo → ReceivesAction → used as control | 0.53 | |
effect
(aspect of
placebo)
→
HasProperty
→
rare
|
0.53 | |
effect
(aspect of
placebo)
→
HasProperty
→
greater
|
0.51 | |
effect
(aspect of
placebo)
→
HasProperty
→
minimal
|
0.50 | |
placebo → HasProperty → powerful | 0.50 | |
placebo → CapableOf → work | 0.50 | |
placebo → HasA → active ingredients | 0.48 | |
effect
(aspect of
placebo)
→
HasProperty
→
mild
|
0.48 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
assessed
|
0.47 | |
effect
(aspect of
placebo)
→
HasProperty
→
strong
|
0.45 | |
placebo → HasProperty → helpful | 0.43 | |
placebo → ReceivesAction → introduced into medical research | 0.43 | |
effect
(aspect of
placebo)
→
HasProperty
→
apparent
|
0.42 | |
placebo → HasProperty → negative | 0.41 | |
placebo → ReceivesAction → added to existing therapy | 0.40 | |
effect
(aspect of
placebo)
→
HasProperty
→
real
|
0.39 | |
placebo → HasProperty → inactive | 0.39 | |
placebo → HasA → direct effect | 0.38 | |
placebo → CapableOf → look like the study drug | 0.38 | |
placebo → HasA → wide range of responses | 0.38 | |
placebo → HasA → therapeutic effect | 0.37 | |
effect
(aspect of
placebo)
→
HasProperty
→
more pronounced
|
0.37 | |
effect
(aspect of
placebo)
→
HasProperty
→
psychological
|
0.37 | |
effect
(aspect of
placebo)
→
HasProperty
→
smaller
|
0.37 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
associated with increasing doses
|
0.37 | |
effect
(aspect of
placebo)
→
CapableOf
→
gain early evidence of effectiveness
|
0.37 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
caused by the treatment
|
0.37 | |
effect
(aspect of
placebo)
→
CapableOf
→
happen
|
0.37 | |
placebo → CapableOf → match zopiclone | 0.36 | |
placebo → ReceivesAction → given in addition | 0.36 | |
placebo → ReceivesAction → taken at bedtime | 0.35 | |
placebo → CapableOf → look like investigational medication | 0.35 | |
placebo → ReceivesAction → added to insulin | 0.35 | |
effect
(aspect of
placebo)
→
HasProperty
→
stronger
|
0.34 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
sustained
|
0.34 | |
effect
(aspect of
placebo)
→
HasProperty
→
variable
|
0.34 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
reported
|
0.34 | |
placebo → CapableOf → look like medicine | 0.33 | |
placebo → DefinedAs → substance | 0.33 | |
placebo → HasProperty → safe | 0.33 | |
placebo → ReceivesAction → compared | 0.33 | |
effect
(aspect of
placebo)
→
HasProperty
→
unreliable
|
0.31 | |
placebo → HasProperty → unethical | 0.31 | |
placebo → DefinedAs → procedure | 0.31 | |
placebo → ReceivesAction → given same way | 0.31 | |
effect
(aspect of
placebo)
→
HasProperty
→
unpredictable
|
0.31 | |
placebo → HasProperty → good | 0.30 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
felt
|
0.30 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
tested
|
0.30 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
monitored
|
0.30 | |
drink → HasA → placebo | 0.29 | |
placebo → ReceivesAction → administered without deception | 0.28 | |
placebo → ReceivesAction → titrated | 0.28 | |
placebo → HasProperty → active | 0.28 | |
placebo → CapableOf → release much dopamine | 0.28 | |
placebo → CapableOf → leave the area | 0.28 | |
placebo → ReceivesAction → discontinued | 0.28 | |
placebo → ReceivesAction → matched to sumatriptan | 0.28 | |
placebo → HasProperty → small | 0.28 | |
placebo → HasProperty → ineffective | 0.28 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
expected
|
0.27 | |
placebo → ReceivesAction → intended to deceive the recipient | 0.26 | |
effect
(aspect of
placebo)
→
HasProperty
→
short-lived
|
0.26 | |
placebo → ReceivesAction → given in clinical context | 0.25 | |
placebo → ReceivesAction → dosed in the morning | 0.25 | |
placebo → CapableOf → evoke understood medical benefits | 0.25 | |
placebo → ReceivesAction → compared to fluoxetine | 0.25 | |
placebo → ReceivesAction → compared to venlafaxine | 0.25 | |
placebo → HasA → aspartame | 0.25 | |
placebo → CapableOf → feel like actual treatment | 0.25 | |
placebo → ReceivesAction → matched for taste | 0.25 | |
placebo → HasProperty → real | 0.25 | |
placebo → CapableOf → cure cancer | 0.25 | |
placebo → ReceivesAction → added to current aed treatment | 0.25 | |
placebo → HasSubevent → case | 0.25 | |
placebo → HasSubevent → lessening | 0.25 | |
placebo → HasSubevent → elimination of pain | 0.25 | |
placebo → ReceivesAction → started | 0.25 | |
placebo → ReceivesAction → added to metformin | 0.25 | |
placebo → HasA → same appearance | 0.25 | |
placebo → ReceivesAction → used to test the effectiveness of treatments | 0.25 | |
placebo → ReceivesAction → administered as sublingual tablet | 0.25 | |
placebo → CapableOf → relieve anxiety | 0.25 | |
placebo → CapableOf → relieve postoperative pain | 0.25 | |
placebo → CapableOf → change the blood chemistry of patients | 0.25 | |
effect
(aspect of
placebo)
→
HasProperty
→
negative
|
0.25 | |
effect
(aspect of
placebo)
→
HasProperty
→
independent
|
0.25 | |
effect
(aspect of
placebo)
→
RelatedTo
→
elevated prolactin levels
|
0.25 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
associated with antidepressant
|
0.25 | |
effect
(aspect of
placebo)
→
HasProperty
→
more marked
|
0.25 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
assessed by coronary angiography
|
0.25 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
corroborated by similar findings
|
0.25 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
evaluated in patient
|
0.25 | |
effect
(aspect of
placebo)
→
HasProperty
→
brief
|
0.25 | |
shampoo → HasA → placebo | 0.25 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
maintained
|
0.25 | |
placebo → AtLocation → tension-type headache | 0.24 | |
effect
(aspect of
placebo)
→
HasProperty
→
serious
|
0.21 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
enhanced
|
0.21 | |
effect
(aspect of
placebo)
→
HasProperty
→
possible
|
0.21 | |
effect
(aspect of
placebo)
→
HasProperty
→
severe
|
0.21 | |
effect
(aspect of
placebo)
→
HasProperty
→
beneficial
|
0.21 | |
placebo → HasProperty → successful | 0.20 | |
placebo → Causes → side effects | 0.20 | |
placebo → CapableOf → activate body's μ-opioid endorphin system | 0.20 | |
placebo → CapableOf → received undue credit | 0.19 | |
placebo → CapableOf → improve a patient's condition | 0.16 | |
placebo → ReceivesAction → considered controversial | 0.16 | |
placebo → ReceivesAction → prescribed under deception | 0.16 | |
placebo → ReceivesAction → designed to be harmless | 0.16 | |
placebo → HasA → medicinal properties | 0.16 | |
placebo → CapableOf → shrink tumor | 0.16 | |
placebo → CapableOf → change the way | 0.16 | |
placebo → AtLocation → episodic migraine | 0.16 | |
placebo → HasA → such a profound effect | 0.16 | |
placebo → ReceivesAction → designed to resemble the treatment | 0.16 | |
placebo → CapableOf → come in any shape | 0.16 | |
effect
(aspect of
placebo)
→
HasProperty
→
large
|
0.16 | |
effect
(aspect of
placebo)
→
CapableOf
→
persist until the end of the trial
|
0.16 | |
effect
(aspect of
placebo)
→
HasProperty
→
horrendous
|
0.16 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
seen in the 2m/kg group
|
0.16 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
difficult to identify
|
0.16 | |
effect
(aspect of
placebo)
→
HasProperty
→
common
|
0.16 | |
effect
(aspect of
placebo)
→
HasProperty
→
superior
|
0.16 | |
effect
(aspect of
placebo)
→
CapableOf
→
last for any duration of time
|
0.14 | |
effect
(aspect of
placebo)
→
ReceivesAction
→
observed in cynomolgus monkeys
|
0.09 | |
placebo → CapableOf → cure disease | 0.03 | |
placebo → CapableOf → presented benefit | 0.00 |